Decoding the link between ischemic stroke and myocardial infarction: a pathophysiological and clinical perspective.

IF 3.4 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL
Ling Chen, Senrong Luo, Mingzhu Feng, Ayush Chandra, José Fidel Baizabal-Carvallo, Mohammad Mofatteh, Jiale Wu, Yuankang He, Zhikai Chen, Xiaoru Zeng, Junrong Tu, Xuejun Wang, Xuxing Liao
{"title":"Decoding the link between ischemic stroke and myocardial infarction: a pathophysiological and clinical perspective.","authors":"Ling Chen, Senrong Luo, Mingzhu Feng, Ayush Chandra, José Fidel Baizabal-Carvallo, Mohammad Mofatteh, Jiale Wu, Yuankang He, Zhikai Chen, Xiaoru Zeng, Junrong Tu, Xuejun Wang, Xuxing Liao","doi":"10.1186/s40001-025-03221-y","DOIUrl":null,"url":null,"abstract":"<p><p>Ischemic stroke and myocardial infarction (MI) are among the leading causes of morbidity and mortality globally. Recent research has increasingly highlighted the significant interrelation between these two vascular events, emphasizing shared pathophysiological mechanisms, overlapping risk factors, and complex clinical outcomes. This review explores the multifaceted relationship between ischemic stroke and MI, focusing on their common underlying mechanisms, including atherosclerosis, thromboembolism, inflammation, and endothelial dysfunction. Both conditions often co-occur due to their shared risk factors, such as hypertension, diabetes, and smoking, leading to compounded health risks for affected individuals. This review aims to synthesize current evidence on the epidemiological, pathophysiological, and clinical interrelationships between ischemic stroke and myocardial infarction, highlighting practical clinical implications and areas for future research. Although ischemic stroke and myocardial infarction primarily affect distinct organ systems, atypical presentations and shared systemic effects can occasionally complicate diagnosis. Cardiac complications are common in acute ischemic stroke, while stroke-like symptoms may arise in patients with acute MI, especially when silent infarctions occur. This diagnostic challenge underscores the need for advanced neuroimaging and cardiac imaging modalities, alongside biomarkers like D-dimer, BNP, and troponins, to enhance early detection and guide therapeutic decisions. Therapeutic strategies for patients with both conditions must be comprehensive, combining acute management with long-term secondary prevention. While antiplatelet therapy, thrombolysis, and anticoagulation are essential in the acute phase, long-term management involves a focus on controlling cardiovascular risk factors, such as blood pressure and cholesterol, and promoting lifestyle modifications. The role of interdisciplinary care-particularly collaboration between cardiology and neurology-is essential for improving outcomes and minimizing complications. The intersection of ischemic stroke and MI presents significant clinical challenges but also opportunities for enhanced patient management. Integrated diagnostic approaches, personalized treatments, and further research into molecular mechanisms are vital for improving the prognosis of individuals affected by both conditions.</p>","PeriodicalId":11949,"journal":{"name":"European Journal of Medical Research","volume":"30 1","pages":"984"},"PeriodicalIF":3.4000,"publicationDate":"2025-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12533319/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s40001-025-03221-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Ischemic stroke and myocardial infarction (MI) are among the leading causes of morbidity and mortality globally. Recent research has increasingly highlighted the significant interrelation between these two vascular events, emphasizing shared pathophysiological mechanisms, overlapping risk factors, and complex clinical outcomes. This review explores the multifaceted relationship between ischemic stroke and MI, focusing on their common underlying mechanisms, including atherosclerosis, thromboembolism, inflammation, and endothelial dysfunction. Both conditions often co-occur due to their shared risk factors, such as hypertension, diabetes, and smoking, leading to compounded health risks for affected individuals. This review aims to synthesize current evidence on the epidemiological, pathophysiological, and clinical interrelationships between ischemic stroke and myocardial infarction, highlighting practical clinical implications and areas for future research. Although ischemic stroke and myocardial infarction primarily affect distinct organ systems, atypical presentations and shared systemic effects can occasionally complicate diagnosis. Cardiac complications are common in acute ischemic stroke, while stroke-like symptoms may arise in patients with acute MI, especially when silent infarctions occur. This diagnostic challenge underscores the need for advanced neuroimaging and cardiac imaging modalities, alongside biomarkers like D-dimer, BNP, and troponins, to enhance early detection and guide therapeutic decisions. Therapeutic strategies for patients with both conditions must be comprehensive, combining acute management with long-term secondary prevention. While antiplatelet therapy, thrombolysis, and anticoagulation are essential in the acute phase, long-term management involves a focus on controlling cardiovascular risk factors, such as blood pressure and cholesterol, and promoting lifestyle modifications. The role of interdisciplinary care-particularly collaboration between cardiology and neurology-is essential for improving outcomes and minimizing complications. The intersection of ischemic stroke and MI presents significant clinical challenges but also opportunities for enhanced patient management. Integrated diagnostic approaches, personalized treatments, and further research into molecular mechanisms are vital for improving the prognosis of individuals affected by both conditions.

Abstract Image

Abstract Image

解码缺血性中风和心肌梗死之间的联系:病理生理和临床的观点。
缺血性中风和心肌梗死(MI)是全球发病率和死亡率的主要原因之一。最近的研究越来越强调这两种血管事件之间的重要相互关系,强调共同的病理生理机制、重叠的危险因素和复杂的临床结果。这篇综述探讨了缺血性卒中和心肌梗死之间的多方面关系,重点讨论了它们共同的潜在机制,包括动脉粥样硬化、血栓栓塞、炎症和内皮功能障碍。由于高血压、糖尿病和吸烟等共同的风险因素,这两种疾病往往同时发生,导致受影响个体的健康风险加剧。本文综述了缺血性脑卒中与心肌梗死之间的流行病学、病理生理和临床相互关系,强调了其临床应用价值和未来的研究方向。虽然缺血性卒中和心肌梗死主要影响不同的器官系统,但不典型的表现和共同的全身影响偶尔会使诊断复杂化。心脏并发症在急性缺血性卒中中很常见,而急性心肌梗死患者可能出现卒中样症状,特别是当无症状性梗死发生时。这一诊断挑战强调需要先进的神经成像和心脏成像模式,以及d -二聚体、BNP和肌钙蛋白等生物标志物,以加强早期检测和指导治疗决策。对这两种情况的患者的治疗策略必须是综合的,将急性管理与长期二级预防相结合。虽然抗血小板治疗、溶栓治疗和抗凝治疗在急性期是必不可少的,但长期管理涉及控制心血管危险因素,如血压和胆固醇,并促进生活方式的改变。跨学科护理的作用——特别是心脏病学和神经学之间的合作——对于改善结果和减少并发症是必不可少的。缺血性脑卒中和心肌梗死的交叉提出了重大的临床挑战,但也为加强患者管理提供了机会。综合诊断方法、个性化治疗和进一步研究分子机制对于改善受这两种疾病影响的个体的预后至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Journal of Medical Research
European Journal of Medical Research 医学-医学:研究与实验
CiteScore
3.20
自引率
0.00%
发文量
247
审稿时长
>12 weeks
期刊介绍: European Journal of Medical Research publishes translational and clinical research of international interest across all medical disciplines, enabling clinicians and other researchers to learn about developments and innovations within these disciplines and across the boundaries between disciplines. The journal publishes high quality research and reviews and aims to ensure that the results of all well-conducted research are published, regardless of their outcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信